Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 1/20 | 0.66 |
| ▸ | CCR1 | P32246 | 4/20 | 0.41 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.41 |
| ▸ | PLD2 | O14939 | 1/20 | 0.41 |
| ▸ | PLD1 | Q13393 | 1/20 | 0.41 |
| ▸ | CCR3 | P51677 | 4/20 | 0.40 |
| ▸ | HTR7 | P34969 | 4/20 | 0.40 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7469453 | 0.94 | MCHR1 (0.59) | MCHR1CCR1KCNA3PLD2PLD1 | |
| SCHEMBL7464781 | 0.87 | MCHR1 (0.73) | MCHR1CCR1KCNA3CCR3HTR7 | |
| SCHEMBL7462229 | 0.85 | MCHR1 (0.62) | MCHR1PLD2 | |
| SCHEMBL7470119 | 0.84 | MCHR1 (0.68) | MCHR1CCR1KCNA3CCR3HTR7 | |
| SCHEMBL7464749 | 0.83 | MCHR1 (0.61) | MCHR1CCR1HTR7ADRA1A | |
| SCHEMBL7467493 | 0.83 | MCHR1 (0.61) | MCHR1CCR1HTR7ADRA1A | |
| SCHEMBL7466997 | 0.83 | MCHR1 (0.61) | MCHR1CCR1KCNA3CCR3HTR7 | |
| SCHEMBL7462164 | 0.83 | MCHR1 (0.62) | MCHR1 | |
| SCHEMBL7463548 | 0.83 | MCHR1 (0.60) | MCHR1CCR1ADRA1A | |
| SCHEMBL7460278 | 0.83 | MCHR1 (0.71) | MCHR1CCR1KCNA3CCR3HTR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1219294-A1 | MELANIN CONCENTRATING HORMONE ANTAGONISTS | Takeda Chemical Industries, Ltd. (JP) | 2002-07-03 | — | — | EP | disclosed |